| Type | Title | Date Released | |
|---|---|---|---|
S-1 | ClearThink Capital Partners, LLC - SPA - 85% of the lowest close over 10 trading days before purchase (also stated as before request). Each Request Notice: up to $1 million and 300% of prior 8-day average volume; daily number not specified. No stated floor; 9.99% ownership cap. | ||
8-K | VSee Health Issues Additional Convertible Promissory Note to Vanquish | ||
8-K | VSee Health, Inc. Announces 1-for-80 Reverse Stock Split | ||
8-K | VSee Health Enters Into $5.0 Million Purchase Agreement with Clearthink Capital Partners | ||
8-K | VSee Health, Inc. Announces Resignation of Director Scott Metzger | ||
8-K | VSee Health, Inc. Announces Results of 2026 Annual Meeting of Stockholders | ||
10-Q | Form 10-Q | ||
SCHEDULE 13G/A | ARMISTICE CAPITAL, LLC (Filed by) | ||
8-K | VSee Health, Inc. Receives Nasdaq Delisting Determination | ||
8-K | VSee Health, Inc. Enters into $336,000 Convertible Promissory Note Financing | ||
8-K | VSee Health, Inc. Enters Settlement Agreement to Resolve Outstanding Disputes with ADI Funding and M2B Funding | ||
DEF 14A | Form DEF 14A |
